Eikon Therapeutics is planning to become the second biotech to go public in 2026, in another sign that the public…
Read More

Eikon Therapeutics is planning to become the second biotech to go public in 2026, in another sign that the public…
Read More
NEW ROADS — The inaugural Clutch for a Cautilize event is this week, proceeds from which will go to supporting…
Read More